NASDAQ : SIBN
SI-BONE, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 21.23 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 951.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 951.50M |
| Enterprise Value | 848.35M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 44.82M |
| Shares Outstanding | 44.82M |
| Shares Change (YoY) | +3.80% |
| Shares Change (QoQ) | +1.18% |
| Owned by Insiders (%) | 3.24% |
| Owned by Institutions (%) | 101.93% |
| Float | 40.02M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.45 |
| Forward PS | 3.79 |
| PB Ratio | 5.20 |
| P/TBV Ratio | 5.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 383.98 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 3.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 9.15 |
| Quick Ratio | 7.39 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.13 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -8.30% |
| Return on Assets (ROA) | -4.62% |
| Return on Invested Capital (ROIC) | -5.13% |
| Return on Capital Employed (ROCE) | -7.90% |
| Weighted Average Cost of Capital (WACC) | 7.76% |
| Revenue Per Employee | $568,093 |
| Profits Per Employee | -$38,915 |
| Employee Count | 376 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 1.20 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +39.12% |
| 50-Day Moving Average | 19.41 |
| 200-Day Moving Average | 16.40 |
| Relative Strength Index (RSI) | 58.65 |
| Average Volume (20 Days) | 617,897 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.70M |
| Short Previous Month | 5.12M |
| Short % of Shares Out | 10.50% |
| Short % of Float | 11.76% |
| Short Ratio (days to cover) | 8.24 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 213.60M |
| Gross Profit | 169.87M |
| Operating Income | -17.75M |
| Pretax Income | -14.63M |
| Net Income | -14.63M |
| EBITDA | -11.33M |
| EBIT | -17.75M |
| Loss Per Share | -$0.33 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 145.94M |
| Total Debt | 42.80M |
| Net Cash | 103.15M |
| Net Cash Per Share | $2.30 |
| Equity (Book Value) | 182.35M |
| Book Value Per Share | 4.08 |
| Working Capital | 195.87M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.48M |
| Capital Expenditures | -6.87M |
| Depreciation & Amortization | 6.42M |
| Net Borrowing | n/a |
| Free Cash Flow | -4.39M |
| FCF Per Share | -$0.10 |
Margins
| Measure | Value |
|---|
| Gross Margin | 79.53% |
| Operating Margin | -8.31% |
| Pretax Margin | -6.85% |
| Profit Margin | -6.85% |
| EBITDA Margin | -5.30% |
| EBIT Margin | -8.31% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.80% |
| Shareholder Yield | -3.80% |
| Earnings Yield | -1.57% |
| FCF Yield | -0.46% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $25.44 |
| Price Target Difference | 19.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 15.55% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.25 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |